- Features
- Performances
- Specifications
- References
- Asahi Kasei Medical Ltd.
- CLINICAL BENEFITS OF β2-MICROGLOBULIN REMOVAL, 2004
- Yamane et al.
- Evaluation of Several PS Membranes for Performance in Eliminating Low Molecular Weight Proteins (LMWPs), From the Point of Albumin Loss into Account.
- Jpn. J. High Performance Membrane '99, Kidney and Dialysis, Vol. 47 supplement, P. 110-113, 1999
- Motomura et al.
- Importance of β2-microglobulin removal in chronic renal replacement therapy.
- Jpn. J. High Performance Membrane '99, Kidney and Dialysis, Vol. 47 supplement, P. 136-139, 1999
- Sohka et al.
- uPAR (CD87) as a Biocompatibility Marker of Dialysis Membrane.
- Blood Purif, 24:236-246, 2006
- Mandolfo et al.
- Leptin and β2-microglobulin kinetics with three different dialysis modalities.
- THE INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS Vol. 29 / no. 10, pp. 949-955, 2006
Trademark
APS is a trademark of Asahi Kasei Medical Co., Ltd.

APS-HE
Please feel free to send us any questions you may have about our products and support.
Share your feelings and experiences when using our products.